The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...
The Diagnostic Labs Market is poised for growth due to rising chronic disease prevalence, aging populations, and advancements in technology. Key opportunities include leveraging AI for better data ...
Fatty liver disease and insulin resistance can be detected through physical signs like a protruding belly, skin tags, and facial puffiness. Dr. Brijmohan Arora highlights these non-invasive indicators ...
Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...
Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...
The FDA is requiring the manufacturer to conduct a postmarketing observational study to further assess the risk of serious liver injury. The study will enroll approximately 200 patients with DMD and ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, will present three ...
Diabetologist Dr Arora emphasises the importance of 6 tests every 6 months for maintaining health as they aid in early ...
Function Health raises $298M to scale its AI platform launch MI Lab expand testing sites and push personalised health ...
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...
Background A 45-year-old white female was admitted to hospital with a 1-week history of right upper quadrant abdominal pain, progressive tiredness and jaundice. Physical examination confirmed jaundice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback